UnknownNot Applicable

Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis

China40 participantsStarted 2014-12

Plain-language summary

The purpose of this study is to determine whether the novel aspiration thrombectomy device combined with catheter-directed thrombolysis is effective in the treatment of acute iliofemoral deep venous thrombosis (IF-DVT).

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of iliofemoral deep venous thrombosis * Symptoms of less than 14 days' duration * With good function status * A life expectancy of more than 1 year * A low risk of bleeding Exclusion Criteria: * Without iliac vein thrombosis * Anticoagulation and/or thrombolysis contraindications * Systemic infection * Heart, hepatic, renal function insufficiency

What they're measuring

patency of lower extremity deep venous

Timeframe: up to 36 months

Trial details

NCT IDNCT02414802

SponsorXuzhou Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12

View on ClinicalTrials.gov More Venous Thrombosis trials